News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
389,070 Results
Type
Article (26720)
Company Profile (114)
Press Release (362236)
Section
Business (101934)
Career Advice (534)
Deals (17973)
Drug Delivery (73)
Drug Development (38696)
Employer Resources (78)
FDA (10688)
Job Trends (9972)
News (175171)
Policy (20594)
Tag
Academia (2103)
Alliances (28300)
Alzheimer's disease (799)
Approvals (10660)
Artificial intelligence (92)
Bankruptcy (144)
Best Places to Work (8877)
Biosimilars (53)
Biotechnology (63)
Breast cancer (66)
Cancer (489)
Cardiovascular disease (58)
Career advice (492)
Cell therapy (97)
Clinical research (30903)
Collaboration (222)
COVID-19 (2134)
Data (562)
Diabetes (94)
Diagnostics (4701)
Drug pricing (78)
Earnings (32979)
Employer resources (69)
Events (70611)
Executive appointments (165)
FDA (11018)
Funding (206)
Gene therapy (74)
GLP-1 (320)
Government (4064)
Healthcare (14852)
Infectious disease (2206)
Inflammatory bowel disease (70)
Interviews (58)
IPO (7627)
Job creations (1402)
Job search strategy (450)
Layoffs (153)
Legal (3883)
Lung cancer (75)
Manufacturing (98)
Medical device (9219)
Medtech (9222)
Mergers & acquisitions (10413)
Metabolic disorders (258)
Neuroscience (940)
NextGen Class of 2024 (4967)
Non-profit (3915)
Northern California (742)
Obesity (164)
Opinion (104)
People (31938)
Phase I (9829)
Phase II (12115)
Phase III (11018)
Pipeline (184)
Policy (49)
Postmarket research (1570)
Preclinical (3116)
Radiopharmaceuticals (146)
Rare diseases (129)
Real estate (2831)
Regulatory (13503)
Research institute (1904)
Southern California (608)
Startups (2081)
United States (7458)
Vaccines (437)
Weight loss (109)
Date
Today (131)
Last 7 days (664)
Last 30 days (2011)
Last 365 days (21840)
2024 (19122)
2023 (24276)
2022 (33711)
2021 (37173)
2020 (37591)
2019 (33265)
2018 (24894)
2017 (17719)
2016 (18869)
2015 (21442)
2014 (16069)
2013 (12733)
2012 (13467)
2011 (13917)
2010 (11937)
Location
Africa (510)
Arizona (91)
Asia (21028)
Australia (3770)
California (1569)
Canada (792)
China (129)
Colorado (83)
Connecticut (100)
Europe (46866)
Florida (257)
Georgia (85)
Illinois (211)
Indiana (164)
Kansas (72)
Maine (57)
Maryland (366)
Massachusetts (1307)
Michigan (91)
Minnesota (132)
New Jersey (600)
New York (534)
North Carolina (458)
Northern California (742)
Ohio (84)
Pennsylvania (514)
South America (669)
Southern California (608)
Texas (203)
Utah (67)
Washington State (236)
389,070 Results for "cardinal health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Telix Announces Cardinal Health as U.S. Commercial Distributor for Zircaix®
September 18, 2024
·
7 min read
Business
Cardinal Health Board of Directors Approves Quarterly Dividend - February 06, 2024
Cardinal Health announced that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company’s capital surplus.
February 6, 2024
·
1 min read
Business
Cardinal Health Reports Second Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
Cardinal Health Reports Second Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook.
February 1, 2024
·
35 min read
Business
Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer
Specialty cancer diagnostics company Precipio, Inc. announces it has entered into a distribution agreement with Cardinal Health for its HemeScreen molecular assay products.
February 6, 2024
·
3 min read
Business
Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2024 on February 1
Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2024 on February 1 , prior to the opening of trading on the New York Stock Exchange.
January 2, 2024
·
1 min read
News
T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens
October 7, 2024
·
6 min read
Business
Cardinal Health Announces Progress on Business and Portfolio Review and Fiscal 2024 Outlook Update
Cardinal Health (NYSE:CAH) today announced progress on the company’s ongoing business and portfolio review, including an updated enterprise operating and segment reporting structure, and an update to its fiscal year 2024 non-GAAP diluted earnings per share (EPS) outlook.
January 9, 2024
·
14 min read
BioMidwest
Cardinal Health launches SmartGown™ EDGE Breathable Surgical Gown with ASSIST™ Instrument Pockets
Cardinal Health (NYSE: CAH) announced today the U.S. launch of its SmartGown™ EDGE Breathable Surgical Gown with ASSIST™ Instrument Pockets, created to provide surgical teams safe and convenient instrument access in the operating room.
November 9, 2023
·
3 min read
Business
Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
Cardinal Health (NYSE: CAH) today reported first quarter fiscal 2024 revenue of $54.8 billion, an increase of 10% from the first quarter of last year.
November 3, 2023
·
27 min read
Drug Development
Cardurion Pharmaceuticals Presents Positive Clinical Results from CARDINAL‑HF Phase 2a Clinical Trial of PDE9 Inhibitor in Patients With Heart Failure
Cardurion Pharmaceuticals, Inc. announced the presentation of positive clinical data from CARDINAL‑HF, the first Phase 2 proof-of-concept clinical trial of a phosphodiesterase-9 inhibitor in patients with heart failure.
May 11, 2024
·
8 min read
1 of 38,907
Next
